Revisions for A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Primary tabs
Revision | Operations |
---|---|
06/23/2023 - 00:20 by Alicanto Admin | Current revision |
Revision | Operations |
---|---|
06/23/2023 - 00:20 by Alicanto Admin | Current revision |